IPO registrations (S-1, F-1) · Registrants

IB Acquisition Corp.

SEC CIK
1998781 · filings on EDGAR ↗
Registration
Form S-1, first filed 2023-11-17, last 2024-03-08; 1 initial registration, 3 amendments
Outcome
Final prospectus filed 2024-03-27; declared effective 2024-03-25
Industry (SIC)
Services-Commercial Physical & Biological Research 8731
Incorporated in
NV
Business address
2500 N MILITARY TRAIL, SUITE 160-A, Boca Raton, FL 33431
EIN
85-2946784
Ticker
IBAC, IBACR (Nasdaq, Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
IB Acquisition Corp. on the corporate pages

Offering terms

Final price
$10.00 per share (424B4 filed 2024-03-27, an initial public offering)
Shares sold
10,000,000
Gross proceeds
$100,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol IBACU
Lead underwriters
Securities, Inc

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 6

FiledFormWhat it isName as filedEDGAR
2023-11-17S-1S-1 (registration)IB Acquisition Corp.0001493152-23-041928 ↗
2023-12-19S-1/AS-1/A (amendment)IB Acquisition Corp.0001493152-23-045466 ↗
2024-01-31S-1/AS-1/A (amendment)IB Acquisition Corp.0001493152-24-004380 ↗
2024-03-08S-1/AS-1/A (amendment)IB Acquisition Corp.0001493152-24-009447 ↗
2024-03-25EFFECTEFFECT (declared effective)IB Acquisition Corp.9999999995-24-000723 ↗
2024-03-27424B4424B4 (final prospectus)IB Acquisition Corp.0001493152-24-011561 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2024-03-08S-1/Aregistration statement$10.0010,000,000$100,000,000Nasdaq IBACU2primary document; price sentence, shares headline, proceeds table, cover names 2document ↗
2024-03-27424B4final prospectus$10.0010,000,000$100,000,000Nasdaq IBACU1primary document; price sentence, shares headline, proceeds table, cover names 1document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Albeck ChristyOfficerChief Finanical Officer12024
I-B Good Works 4, LLCOther12024
JOYCE JOHN RDirector12024
Lopez Adelmo SDirector,OfficerChief Executive Officer12024
Panigone SilviaDirector12024
Zhang JianDirector12024
AQR Arbitrage LLCTenPercentOwner82025–2026
AQR Capital Management Holdings, LLCTenPercentOwner82025–2026
AQR CAPITAL MANAGEMENT LLCTenPercentOwner82025–2026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
SEC filerIB Acquisition Corp.SEC filers (EDGAR)CIK (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Services-Commercial Physical & Biological Research, FL first:

More with this interest.

In other datasets, the same topic (Medical research) in FL:

Interests: Services-Commercial Physical & Biological Research · Medical research